scutellarin has been researched along with Learning Disabilities in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, TD; Kim, DK; Kim, P; Kweon, KJ; Maeng, S; Shin, JW; Sohn, NW | 1 |
| Guan, ZZ; Guo, LL; Wang, YL | 1 |
2 other study(ies) available for scutellarin and Learning Disabilities
| Article | Year |
|---|---|
Scutellarin Ameliorates Learning and Memory Deficit via Suppressing β-Amyloid Formation and Microglial Activation in Rats with Chronic Cerebral Hypoperfusion.
Topics: Administration, Oral; Amyloid beta-Peptides; Animals; Apigenin; Brain; Calcium-Binding Proteins; Chronic Disease; Erigeron; Glucuronates; Hypoxia-Ischemia, Brain; Learning Disabilities; Male; Memory Disorders; Microfilament Proteins; Microglia; Peptide Fragments; Phytotherapy; Rats, Sprague-Dawley | 2018 |
Scutellarin protects against Aβ-induced learning and memory deficits in rats: involvement of nicotinic acetylcholine receptors and cholinesterase.
Topics: Amyloid beta-Peptides; Animals; Apigenin; Base Sequence; Blotting, Western; Butyrylcholinesterase; Cholinesterases; DNA Primers; Glucuronates; Injections, Intraventricular; Learning Disabilities; Male; Memory Disorders; Polymerase Chain Reaction; Rats; Rats, Wistar; Receptors, Nicotinic | 2011 |